President Trump unveiled TrumpRx on Thursday evening, promising Americans lower prescription drug prices through a government-run purchasing platform. But as the administration celebrates what it calls a breakthrough in affordable medication access, health policy experts are sounding alarms about unintended consequences that could ultimately harm the very consumers the program aims to help. The new […]

The postTrumpRx announcement draws criticism from Cato Instituteappeared first onRolling Out.